Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Research and Studies Center on the Integument (CERT) | UNKNOWN |
| University of Franche-Comté | OTHER |
| Centre Hospitalier Universitaire de Besancon | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The main objective of this trial is to evaluate the effect of the daily dose of X34 dietary supplement on skin radiance (clinical assessment) for 8 weeks.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| X34 | Experimental | Arm supplemented with X34 |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| X34 | Dietary Supplement | Dietary supplement named X34 |
|
| Measure | Description | Time Frame |
|---|---|---|
| Skin radiance: clinical scoring | At 0 week and 8 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Subject self-assessments | Subjects will evaluate the radiance of their complexion by self-assessment. | At 0 week and 8 weeks |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| C413183 | 1,4-bis(3-carboxy-4-hydroxyphenylethenyl)-benzene |
Not provided
Not provided
Not provided
| Clinical Investigation Center (CIC) INSERM 1431 |
| UNKNOWN |
| INSERM UMR1098 | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided